Dr. Mark Lebwohl: "Experimental Psoriasis Treatment Shows Promise"
The chronic skin condition psoriasis could be treated with a compound that targets a small piece of genetic material in cells, new research in animals suggests.
Mark Lebwohl, MD, Professor and Chair of Dermatology at The Mount Sinai Hospital, said he doubts the study will result in new psoriasis drugs anytime soon. "Since the molecule is a biological one, it will be costly to make," said Dr. Lebwohl. Learn more